Delek Logistics Partners (DKL) achieved 52 consecutive quarterly distribution increases over 13 years with an 8.5% yield, but 2025 operating cash flow of $237.1M covered only $238.1M in distributions ...

Tue, March 24, 2026 at 8:42 PM UTC Delek Logistics Partners, LP (NYSE:DKL), which plays a critical role in the energy supply chain, just hit a milestone that almost no MLP can claim: 52 consecutive ...

Qatar halts output of LNG, associated products Aramco's Ras Tanura refinery hit by drone, source says Major Israeli gas fields, including Leviathan, offline Most output in Iraqi Kurdistan shut down ...

Voice-to-text on Android is really good if you’re using a Pixel, and pretty hit or miss everywhere else. But the new “Wispr Flow” app promises some big improvements to voice-to-text on Android, all ...

Alerian MLP ETF (AMLP) yields 7.9% from energy infrastructure. The fund’s top six holdings represent 77% of assets. Enterprise Products Partners distributes $4.5B annually. It generates only $3.6B in ...

The Fontan operation is a palliative technique for patients born with single ventricle heart disease. The superior vena cava (SVC), inferior vena cava (IVC), and hepatic veins are connected to the ...

A buyback bonanza could boost Enterprise Products Partners' distribution per unit. The midstream leader is also poised for breakout growth in 2027. Enterprise Products Partners just finished a banner ...

A comprehensive, modular Python automation system for HEC-RAS flood analysis workflows. This professional-grade tool demonstrates advanced hydraulic modeling capabilities, Python integration, and ...

Regardless of which edition you pick, you'll get a remastered edition of Flow director Gints Zilbalodis' first animated movie, the 2019 fantasy adventure Away. It also comes with multiple inserts, two ...

Effective wastewater treatment relies on the recycling of activated sludge (RAS) to sustain microbial activity in aeration tanks. Future developments aim to address issues like microplastic clogging ...

The number of biopharma M&A deals announced so far this year is higher than the yearly average for the last 15 years, while deal value has already eclipsed last year’s total. For 2025, a mean of 21 ...